BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 28844707)

  • 21. Tumor growth kinetics versus RECIST to assess response to locoregional therapy in breast cancer liver metastases.
    Seyal AR; Parekh K; Velichko YS; Salem R; Yaghmai V
    Acad Radiol; 2014 Aug; 21(8):950-7. PubMed ID: 24833565
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Liver metastases from neuroendocrine tumours of the gastroenteropancreatic system--therapeutic strategies].
    Auernhammer CJ; Jauch KW; Hoffmann JN
    Zentralbl Chir; 2009 Sep; 134(5):410-7. PubMed ID: 19757340
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High sensitivity of diffusion-weighted MR imaging for the detection of liver metastases from neuroendocrine tumors: comparison with T2-weighted and dynamic gadolinium-enhanced MR imaging.
    d'Assignies G; Fina P; Bruno O; Vullierme MP; Tubach F; Paradis V; Sauvanet A; Ruszniewski P; Vilgrain V
    Radiology; 2013 Aug; 268(2):390-9. PubMed ID: 23533288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Are recist criteria adequate in assessing the response to therapy in metastatic NEN?
    Vullierme MP; Ruszniewski P; de Mestier L
    Rev Endocr Metab Disord; 2021 Sep; 22(3):637-645. PubMed ID: 33871762
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Value of retrospective fusion of PET and MR images in detection of hepatic metastases: comparison with 18F-FDG PET/CT and Gd-EOB-DTPA-enhanced MRI.
    Donati OF; Hany TF; Reiner CS; von Schulthess GK; Marincek B; Seifert B; Weishaupt D
    J Nucl Med; 2010 May; 51(5):692-9. PubMed ID: 20395324
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fluid-fluid level in hepatic metastases: a characteristic sign of metastases of neuroendocrine origin.
    Sommer WH; Zech CJ; Bamberg F; Auernhammer CJ; Helck A; Paprottka PM; Notohamiprodjo M; Reiser MF; Herrmann KA
    Eur J Radiol; 2012 Sep; 81(9):2127-32. PubMed ID: 21978774
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Small colorectal liver metastases: detection with SPIO-enhanced MRI in comparison with gadobenate dimeglumine-enhanced MRI and CT imaging.
    Hekimoglu K; Ustundag Y; Dusak A; Kalaycioglu B; Besir H; Engin H; Erdem O
    Eur J Radiol; 2011 Mar; 77(3):468-72. PubMed ID: 19781882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection and classification of different liver lesions: comparison of Gd-EOB-DTPA-enhanced MRI versus multiphasic spiral CT in a clinical single centre investigation.
    Böttcher J; Hansch A; Pfeil A; Schmidt P; Malich A; Schneeweiss A; Maurer MH; Streitparth F; Teichgräber UK; Renz DM
    Eur J Radiol; 2013 Nov; 82(11):1860-9. PubMed ID: 23932636
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rectal neuroendocrine tumor presenting as a polyp with hepatic metastases.
    Meriam S; Trad D; Jouini R; Haddad D; Ouakaa A
    Gastrointest Endosc; 2019 Oct; 90(4):688-689. PubMed ID: 31375265
    [No Abstract]   [Full Text] [Related]  

  • 30. Retrospective comparison of approaches to evaluating inter-observer variability in CT tumour measurements in an academic health centre.
    Woo M; Heo M; Devane AM; Lowe SC; Gimbel RW
    BMJ Open; 2020 Nov; 10(11):e040096. PubMed ID: 33191265
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prospective Study of 68Ga-DOTATATE Positron Emission Tomography/Computed Tomography for Detecting Gastro-Entero-Pancreatic Neuroendocrine Tumors and Unknown Primary Sites.
    Sadowski SM; Neychev V; Millo C; Shih J; Nilubol N; Herscovitch P; Pacak K; Marx SJ; Kebebew E
    J Clin Oncol; 2016 Feb; 34(6):588-96. PubMed ID: 26712231
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liver metastases from colorectal cancer treated with conventional and antiangiogenetic chemotherapy: evaluation with liver computed tomography perfusion and magnetic resonance diffusion-weighted imaging.
    Anzidei M; Napoli A; Zaccagna F; Cartocci G; Saba L; Menichini G; Cavallo Marincola B; Marotta E; Di Mare L; Catalano C; Passariello R
    J Comput Assist Tomogr; 2011; 35(6):690-6. PubMed ID: 22082538
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CT-based radiomics to distinguish progressive from stable neuroendocrine liver metastases treated with somatostatin analogues: an explorative study.
    Staal FC; Taghavi M; Hong EK; Tissier R; van Treijen M; Heeres BC; van der Zee D; Tesselaar ME; Beets-Tan RG; Maas M
    Acta Radiol; 2023 Mar; 64(3):1062-1070. PubMed ID: 35702011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary tumour resection may improve survival in functional well-differentiated neuroendocrine tumours metastatic to the liver.
    Citterio D; Pusceddu S; Facciorusso A; Coppa J; Milione M; Buzzoni R; Bongini M; deBraud F; Mazzaferro V
    Eur J Surg Oncol; 2017 Feb; 43(2):380-387. PubMed ID: 27956320
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Duodenal neuroendocrine tumors: retrospective evaluation of CT imaging features and pattern of metastatic disease on dual-phase MDCT with pathologic correlation.
    Tsai SD; Kawamoto S; Wolfgang CL; Hruban RH; Fishman EK
    Abdom Imaging; 2015 Jun; 40(5):1121-30. PubMed ID: 25504375
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Imaging of neuroendocrine tumors: accuracy of helical CT versus SRS.
    Kumbasar B; Kamel IR; Tekes A; Eng J; Fishman EK; Wahl RL
    Abdom Imaging; 2004; 29(6):696-702. PubMed ID: 15162235
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proposal of early CT morphological criteria for response of liver metastases to systemic treatments in gastroenteropancreatic neuroendocrine tumors: Alternatives to RECIST.
    de Mestier L; Resche-Rigon M; Dromain C; Lamarca A; La Salvia A; de Baker L; Fehrenbach U; Pusceddu S; Colao A; Borbath I; de Haas R; Rinzivillo M; Zerbi A; Funicelli L; de Herder WW; Selberherr A; Wagner AD; Manoharan P; De Cima A; Lybaert W; Jann H; Prinzi N; Faggiano A; Annet L; Walenkamp A; Panzuto F; Pedicini V; Pitoni MG; Siebenhuener A; Mayerhoefer ME; Ruszniewski P; Vullierme MP
    J Neuroendocrinol; 2023 Jun; 35(6):e13311. PubMed ID: 37345276
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Irreversible electroporation of hepatocellular carcinoma: preliminary report on the diagnostic accuracy of magnetic resonance, computer tomography, and contrast-enhanced ultrasound in evaluation of the ablated area.
    Granata V; de Lutio di Castelguidone E; Fusco R; Catalano O; Piccirillo M; Palaia R; Izzo F; Gallipoli AD; Petrillo A
    Radiol Med; 2016 Feb; 121(2):122-31. PubMed ID: 26345332
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radiotherapy of liver metastases. Comparison of target volumes and dose-volume histograms employing CT- or MRI-based treatment planning.
    Pech M; Mohnike K; Wieners G; Bialek E; Dudeck O; Seidensticker M; Peters N; Wust P; Gademann G; Ricke J
    Strahlenther Onkol; 2008 May; 184(5):256-61. PubMed ID: 18427756
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is multidetector computed tomography comparable to magnetic resonance imaging for assessment of lumbar foraminal stenosis?
    Kang WY; Ahn JM; Lee JW; Lee E; Bae YJ; Seo J; Kim J; Kang HS
    Acta Radiol; 2017 Feb; 58(2):197-203. PubMed ID: 27055917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.